3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
3
Sarcoma
1
Recurrence
1
Neoplasm Metastasis
1
Brest Cancer
1
Interventions
eribulin
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Brest Cancer
×
eribulin
×
Clear all
NCT07333937
2026-01-12
NETHER
Xijing Hospital
Phase 2
Not yet recruiting
35 enrolled